Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN025524-003
Application #
2302441
Study Section
Project Start
1992-09-30
Project End
2008-09-29
Budget Start
1993-09-22
Budget End
1994-09-29
Support Year
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of Utah
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Hawkins, Makenzie L; Buys, Saundra S; Gren, Lisa H et al. (2017) Do cancer survivors develop healthier lifestyle behaviors than the cancer-free population in the PLCO study? J Cancer Surviv 11:233-245
Zhu, Claire S; Huang, Wen-Yi; Pinsky, Paul F et al. (2016) The Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial Pathology Tissue Resource. Cancer Epidemiol Biomarkers Prev 25:1635-1642
Kang, Xiaozheng; Liu, Hongliang; Onaitis, Mark W et al. (2016) Polymorphisms of the centrosomal gene (FGFR1OP) and lung cancer risk: a meta-analysis of 14,463 cases and 44,188 controls. Carcinogenesis 37:280-289
Pretzel, Shannon M; Andrews, Tara S; Broski, Karen et al. (2015) Participants' Views of Retention Materials Used in the PLCO Cancer Screening Trial. Clin Med Res 13:139-48
Cote, Michele L; Alhajj, Tala; Ruterbusch, Julie J et al. (2015) Risk factors for endometrial cancer in black and white women: a pooled analysis from the Epidemiology of Endometrial Cancer Consortium (E2C2). Cancer Causes Control 26:287-296
Brenner, Darren R; Amos, Christopher I; Brhane, Yonathan et al. (2015) Identification of lung cancer histology-specific variants applying Bayesian framework variant prioritization approaches within the TRICL and ILCCO consortia. Carcinogenesis 36:1314-26
Kvale, Paul A; Johnson, Christine Cole; Tammemägi, Martin et al. (2014) Interval lung cancers not detected on screening chest X-rays: How are they different? Lung Cancer 86:41-6
Wang, Yufei; McKay, James D; Rafnar, Thorunn et al. (2014) Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer. Nat Genet 46:736-41
Gierada, David S; Pinsky, Paul; Nath, Hrudaya et al. (2014) Projected outcomes using different nodule sizes to define a positive CT lung cancer screening examination. J Natl Cancer Inst 106:
Patz Jr, Edward F; Pinsky, Paul; Gatsonis, Constantine et al. (2014) Overdiagnosis in low-dose computed tomography screening for lung cancer. JAMA Intern Med 174:269-74

Showing the most recent 10 out of 46 publications